Feb 26, 2021
Autor: Euler Manenti
Ref: SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018 Nov 9.
Feb 24, 2021
Autor: Carlos Eduardo Barra Couri
Ref: Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.
Feb 22, 2021
Autor: Cristiano Barcellos
Ref: Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function. J Steroid Biochem Mol Biol. 2015 Nov;154:254-66.
Feb 19, 2021
Autor: Mônica Gabbay
Ref: Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2018 May;34(4):e2983.
Feb 18, 2021
Autor: André Vianna
Ref: International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640.